Prostatepredict. Development of a prognostic test to predict the likelihood of aggressive disease after surgery in prostate cancer
The main objective of this project is to develop a system for prostate cancer prognosis that allows reliable prediction of the possibility of recurrence in patients who undergo prostatectomy.
Transbiomed (Amadix), Bellvitge Biomedical Research Institute (IDIBELL), Vall d’Hebron Research Institute and Hospital 12 de octubre
Cofunded by the Ministerio de Economía y competitividad in the frame of the Programa Nacional de cooperación Público-Privada, Subprograma INNPACTO, within the línea Instrumental de Articulación e Internacionalización del Sistema, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008-2011, and by the European Regional Development Funds (FEDER).
2014-2016
